Maisonneuve-Rosemont Hospital Université de Montréal
photo entête

Health professionals

Should you refer a patient to MRH’s bone marrow transplant (BMT) team?

Whether of the autologous or allogeneic type, hematopoietic stem cell transplantation is a therapeutic procedure that can be contemplated during the regression phase of a blood disease or cancer, but it seldom constitutes the first line of treatment. In accordance with the diagnosis, the patient will initially be treated through chemotherapy and/or radiotherapy. Hematopoietic transplantation will be considered on the basis of the original diagnosis, the risk factors associated with the disease and the response to the treatment.

A number of other factors may influence the therapeutic strategy, including:

Before referring patients to the BMT team, therefore, it is important to verify whether they are eligible for a transplant.

Indications for transplant

The following pages outline the indications for transplant used for the most common hematologic diseases by MRH’s BMT team.

Have any questions?

Should you have any doubts or questions about the indications for transplant, feel free to contact us.